News

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.
Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...
The weight loss and diabetes drug, which is only available on prescription, should be on pharmacy shelves within days ending ...
W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...
A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...
GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...
A new bill could make the price of prescription drugs known for weight loss cheaper for the state of Ohio to buy for its ...
COLUMBUS, Ohio (WCMH) — A new bill could make the price of prescription drugs known for weight loss cheaper for the state to buy for its employees. The bill would eliminate pharmacy benefit ...